Infinity Pharmaceuticals, Inc.’s INFI shares plunged 69.2% to hit a new 52-week low, after the company announced unfavorable data from the phase II DYNAMO study on its lead candidate, duvelisib, for ...
Infinity Pharmaceuticals Inc (NASDAQ: INFI) reported an update from its MARIO-3 study of eganelisib in combination with atezolizumab and nab-paclitaxel in front-line metastatic triple-negative breast ...
The first trailer for Marvel's Avengers: Infinity War has arrived! And it did not disappoint with its assemblage and mix of the many MCU heroes. Doctor Strange and Hulk? Scarlet Witch and a... human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results